Literature DB >> 29804909

Familial chylomicronemia syndrome: Bringing to life dietary recommendations throughout the life span.

Lauren Williams1, Katherine S Rhodes2, Wahida Karmally3, Lori A Welstead4, Lori Alexander5, Lindsey Sutton6.   

Abstract

BACKGROUND: Familial chylomicronemia syndrome (FCS) is a rare autosomal recessive disorder with loss of function mutations of lipoprotein lipase resulting in hypertriglyceridemia and accumulation of chylomicrons in plasma, often leading to acute pancreatitis. The mainstay of treatment is a specialized very-low-fat diet. Even adhering to the diet, some patients may experience high triglycerides and pancreatitis. There currently are no comprehensive dietary guidelines.
OBJECTIVE: To report best practices and develop comprehensive dietary guidelines for nutrition therapy in patients with FCS.
METHODS: Registered dietitian nutritionists (RDNs) convened to develop this report based on experience treating patients with FCS and a review of current literature on the topic. One author provided a patient perspective of living with FCS.
RESULTS: This report provides guidelines and rationales for nutrition therapy associated with FCS across the life span. The top global guidelines are to (1) limit fat to <15 to 20 g per day (<10%-15% of total daily energy intake); (2) meet recommendations for essential fatty acids: α-linolenic acid and linoleic acid; (3) choose complex carbohydrate foods while limiting simple and refined carbohydrate foods; (4) supplement with fat-soluble vitamins, minerals, and medium-chain triglyceride oil, as needed; (5) adjust calories for weight management. Recommended foods include vegetables, whole grains, legumes, lean protein foods, fruits in limited amounts, and fat-free milk products without added sugars. Foods to avoid include alcohol and products high in sugar.
CONCLUSIONS: These patient-centered nutrition guidelines provide guidance to help patients adhere to the recommended diet and optimize nutritional needs.
Copyright © 2018 National Lipid Association. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Chylomicronemia; Dietary recommendations; Familial chylomicronemia syndrome (FCS); Hyperlipoproteinemia; Hypertriglyceridemia; Lipoprotein lipase deficiency; Low-fat diet; Pancreatitis; Pediatrics; Type 1 hyperlipoproteinemia

Mesh:

Year:  2018        PMID: 29804909     DOI: 10.1016/j.jacl.2018.04.010

Source DB:  PubMed          Journal:  J Clin Lipidol        ISSN: 1876-4789            Impact factor:   4.766


  10 in total

Review 1.  Triglycerides: Emerging Targets in Diabetes Care? Review of Moderate Hypertriglyceridemia in Diabetes.

Authors:  Anastasia-Stefania Alexopoulos; Ali Qamar; Kathryn Hutchins; Matthew J Crowley; Bryan C Batch; John R Guyton
Journal:  Curr Diab Rep       Date:  2019-02-26       Impact factor: 4.810

Review 2.  Clinical Management of Hypertriglyceridemia in the Prevention of Cardiovascular Disease and Pancreatitis.

Authors:  Patricia Hernandez; Neena Passi; Taher Modarressi; Vivek Kulkarni; Meshal Soni; Fran Burke; Archna Bajaj; Daniel Soffer
Journal:  Curr Atheroscler Rep       Date:  2021-09-13       Impact factor: 5.113

3.  Efficacy and safety of the apolipoprotein C-III inhibitor Volanesorsen: a systematic evaluation and meta-analysis.

Authors:  Yonglang Cheng; Tongxi Li; Peng Tan; Yichao Du; Zhiwei Huang; Hao Shi; Tianying Cai; Yifan Chen; Wenguang Fu
Journal:  Endocrine       Date:  2022-03-17       Impact factor: 3.633

4.  Differentiating Familial Chylomicronemia Syndrome From Multifactorial Severe Hypertriglyceridemia by Clinical Profiles.

Authors:  Louis St L O'Dea; James MacDougall; Veronica J Alexander; Andres Digenio; Brant Hubbard; Marcello Arca; Patrick M Moriarty; John J P Kastelein; Eric Bruckert; Handrean Soran; Joseph L Witztum; Robert A Hegele; Daniel Gaudet
Journal:  J Endocr Soc       Date:  2019-10-11

5.  Familial chylomicronemia syndrome: a case report.

Authors:  Ammu Thampi Susheela; Padmesh Vadakapet; Lekshmi Pillai; Susheela Thampi
Journal:  J Med Case Rep       Date:  2021-01-08

6.  Familial chylomicronemia syndrome due to a heterozygous deletion of the chromosome 8 treated with the apoCIII inhibitor volanesorsen: A case report.

Authors:  Adrienn Tünnemann-Tarr; Hubert Scharnagl; Julius L Katzmann; Paulina Stürzebecher; Ulrich Laufs
Journal:  Medicine (Baltimore)       Date:  2021-10-22       Impact factor: 1.817

7.  Recurrent Pancreatitis in a Pregnant Woman with Severe Hypertriglyceridemia Successfully Managed by Multiple Plasmapheresis.

Authors:  JungMin Choi; Hyungsuk Kim; JongKwan Jun; JiKon Ryu; Hae-Young Lee
Journal:  J Atheroscler Thromb       Date:  2021-07-02       Impact factor: 4.394

Review 8.  Hypertriglyceridemia: new approaches in management and treatment.

Authors:  Anna Wolska; Zhi-Hong Yang; Alan T Remaley
Journal:  Curr Opin Lipidol       Date:  2020-12       Impact factor: 4.616

9.  Significant Quality of Life Improvement Observed in a Patient With FCS Associated With a Marked Reduction in Triglycerides.

Authors:  Ioanna Gouni-Berthold
Journal:  J Endocr Soc       Date:  2019-12-23

Review 10.  Current Diagnosis and Management of Primary Chylomicronemia.

Authors:  Hiroaki Okazaki; Takanari Gotoda; Masatsune Ogura; Shun Ishibashi; Kyoko Inagaki; Hiroyuki Daida; Toshio Hayashi; Mika Hori; Daisaku Masuda; Kota Matsuki; Shinji Yokoyama; Mariko Harada-Shiba
Journal:  J Atheroscler Thromb       Date:  2021-05-13       Impact factor: 4.928

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.